Monday, July 24, 2023
Fractus, a renowned company known for its ground-breaking antenna technology and contributions to the telecommunications sector, is now venturing into healthcare with its latest innovation. They have successfully developed wireless implantable device technology, promising to revolutionize the way patients are monitored remotely and driving the adoption of teleconsultation services through wireless connectivity. This advanced technology provides real-time data and feedback, with the potential to significantly enhance patient care.
American Heart Association, approximately 92.1 million adults in the United States are affected by cardiovascular disease, leading to nearly 500,000 annual pacemaker insertions in the country. The global market for cardiac rhythm management devices was valued at $10.2 billion in 2018 and is expected to grow at a CAGR of 4.2% until 2025. In the US, the market is projected to reach a value of $6.3 billion by 2025.
With a history of technological breakthroughs since its establishment in 1999 in Barcelona, Spain, Fractus has made a substantial impact on the telecommunications industry. Notably, their contributions eliminated the need for external cell phone antennas, enabling global connectivity while maintaining sleek designs. Now, Fractus is bringing its innovative expertise to the healthcare sector with wireless implantable device technology, promising a new era in remote patient monitoring and teleconsultation services.
Source: prnewswire.com
